Malvindi Pietro Giorgio, Cappai Antioco, Raffa Giuseppe Maria, Barbone Alessandro, Basciu Alessio, Citterio Enrico, Ornaghi Diego, Tarelli Giuseppe, Settepani Fabrizio
Department of Cardiac Surgery, IRCCS Istituto Clinico Humanitas, 20089 Rozzano, Italy.
Tex Heart Inst J. 2013;40(3):274-80.
Aortic false aneurysm is a rare complication after cardiac surgery. In recent years, improved results have been reported in regard to the surgical management of these high-risk lesions. We retrospectively examined 28 consecutive cases (in 27 patients) of postsurgical aortic false aneurysm diagnosed at our institution from May 1999 through December 2011. Twenty-four patients underwent reoperation. Cardiopulmonary bypass was instituted before sternotomy in 15 patients (63%). Isolated repair of the aortic false aneurysm was performed in 15 patients. Four patients (including one who had already undergone repeat false-aneurysm repair) declined surgery in favor of clinical monitoring. Eleven patients were asymptomatic at the time of diagnosis. In the other 16, the main cause was infection in 7, and previous operation for acute aortic dissection in 9. The in-hospital mortality rate was 16.6% (4 patients, 3 of whom had infective false aneurysms). Relevant postoperative sequelae were noted in 7 patients (29%). The cumulative 1-year and 5-year survival rates were 83% and 62%, respectively. The 4 patients who did not undergo reoperation were alive at a median interval of 23 months (range, 9-37 mo). Two underwent imaging evaluations; in one, computed tomography revealed an 8-mm increase of the false aneurysm's maximal diameter at 34 months. Aortic false aneurysm can develop silently. Surgical procedures should be proposed even to asymptomatic patients because of the unpredictable evolution of the condition. Radical aortic-graft replacement should be chosen rather than simple repair, because recurrent false aneurysm is possible.
主动脉假性动脉瘤是心脏手术后一种罕见的并发症。近年来,关于这些高危病变的外科治疗已有改善的结果报道。我们回顾性研究了1999年5月至2011年12月在我院诊断的28例(27例患者)术后主动脉假性动脉瘤连续病例。24例患者接受了再次手术。15例患者(63%)在胸骨切开术前建立了体外循环。15例患者进行了主动脉假性动脉瘤的孤立修复。4例患者(包括1例已经接受过假性动脉瘤重复修复的患者)拒绝手术而选择临床监测。11例患者在诊断时无症状。在其他16例中,主要病因是7例感染,9例既往有急性主动脉夹层手术史。住院死亡率为16.6%(4例患者,其中3例为感染性假性动脉瘤)。7例患者(29%)出现相关术后后遗症。1年和5年累积生存率分别为83%和62%。4例未接受再次手术的患者存活,中位间隔时间为23个月(范围9 - 3个月)。2例患者接受了影像学评估;其中1例,计算机断层扫描显示在34个月时假性动脉瘤最大直径增加了8毫米。主动脉假性动脉瘤可能悄然发展。由于病情发展不可预测,即使对无症状患者也应建议进行手术。应选择彻底的主动脉移植置换术而非简单修复,因为可能会复发假性动脉瘤。